Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash flows from operating activities:    
Net income $ 350,119 $ 312,018
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 200,021 192,966
Non-cash interest expense, net of amortization of premium 16,515 16,506
Provision for doubtful accounts 32,875 28,571
Amortization of deferred income related to equity method investment (2,081) (2,082)
Loss on extinguishment of debt and credit facilities, net 0 124,348
Gain on unconsolidated entity investments, net (2,677) (2,831)
Dividend received from unconsolidated entity investment 12,873 17,707
Loss on disposal of assets 217 128
Loss on change in value of derivatives 34,485 0
Share-based payment expense 57,832 49,774
Deferred income taxes 244,667 219,184
Other non-cash purchase price adjustments (2,836) (206,786)
Changes in operating assets and liabilities:    
Accounts receivable (31,584) (25,207)
Receivables from distributors (15,172) 23,606
Inventory (10,487) 11,095
Related party assets (995) 2,077
Prepaid expenses and other current assets (16,319) (6,665)
Other long-term assets 1,567 (363)
Accounts payable and accrued expenses (36,861) (58,680)
Accrued interest 33,899 19,964
Deferred revenue 25,225 34,530
Related party liabilities (1,261) (635)
Other long-term liabilities (1,854) (4,968)
Net cash provided by operating activities 888,168 744,257
Cash flows from investing activities:    
Additions to property and equipment (87,244) (118,235)
Purchases of restricted and other investments 0 (1,719)
Acquisition of business, net of cash acquired 1,144 0
Return of capital from investment in unconsolidated entity 24,178 0
Net cash used in investing activities (61,922) (119,954)
Cash flows from financing activities:    
Proceeds from exercise of stock options 331 21,819
Taxes paid in lieu of shares issued for stock-based compensation (24,781) (27,913)
Proceeds from long-term borrowings and revolving credit facility, net of costs 2,151,205 2,532,137
Payment of premiums on redemption of debt 0 (116,410)
Repayment of long-term borrowings and revolving credit facility (993,772) (1,085,737)
Repayment of related party long-term borrowings 0 (150,000)
Common stock repurchased and retired (1,990,449) (1,602,360)
Net cash used in financing activities (857,466) (428,464)
Net (decrease) increase in cash and cash equivalents (31,220) 195,839
Cash and cash equivalents at beginning of period 134,805 520,945
Cash and cash equivalents at end of period 103,585 716,784
Cash paid during the period for:    
Interest, net of amounts capitalized 138,388 109,476
Non-cash investing and financing activities:    
Capital lease obligations incurred to acquire assets 719 8,870
Conversion of Series B preferred stock to common stock 0 1,293
Treasury stock not yet settled 15,565 0
Conversion of 7% Exchangeable Notes to common stock, net of debt issuance and deferred financing costs 6 45,097
Purchase price accounting adjustments to goodwill $ 1,698 $ 0